Tower Research Capital (TRC)’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.3K | Sell |
9,394
-266
| -3% | -$915 | ﹤0.01% | 3345 |
|
|
2025
Q1 | $20.6K | Buy |
9,660
+3,951
| +69% | +$8.42K | ﹤0.01% | 2934 |
|
|
2024
Q4 | $18.2K | Buy |
5,709
+3,509
| +160% | +$11.2K | ﹤0.01% | 3265 |
|
|
2024
Q3 | $29.4K | Buy |
+2,200
| New | +$29.4K | ﹤0.01% | 3014 |
|
|
2024
Q2 | – | Sell |
-1,088
| Closed | -$12.9K | – | 5710 |
|
|
2024
Q1 | $12.9K | Sell |
1,088
-839
| -44% | -$9.99K | ﹤0.01% | 3431 |
|
|
2023
Q4 | $7.75K | Buy |
1,927
+522
| +37% | +$2.1K | ﹤0.01% | 4584 |
|
|
2023
Q3 | $3.85K | Buy |
1,405
+283
| +25% | +$775 | ﹤0.01% | 4946 |
|
|
2023
Q2 | $7.5K | Buy |
1,122
+452
| +67% | +$3.02K | ﹤0.01% | 4539 |
|
|
2023
Q1 | $4K | Sell |
670
-1,481
| -69% | -$8.84K | ﹤0.01% | 5055 |
|
|
2022
Q4 | $5K | Buy |
+2,151
| New | +$5K | ﹤0.01% | 4841 |
|
|
2022
Q2 | – | Sell |
-1,380
| Closed | -$5K | – | 6095 |
|
|
2022
Q1 | $5K | Buy |
1,380
+572
| +71% | +$2.07K | ﹤0.01% | 5025 |
|
|
2021
Q4 | $3K | Buy |
+808
| New | +$3K | ﹤0.01% | 5424 |
|
|
2021
Q3 | – | Sell |
-96
| Closed | -$1K | – | 5789 |
|
|
2021
Q2 | $1K | Sell |
96
-347
| -78% | -$3.62K | ﹤0.01% | 5180 |
|
|
2021
Q1 | $5K | Sell |
443
-3,560
| -89% | -$40.2K | ﹤0.01% | 4653 |
|
|
2020
Q4 | $18K | Buy |
+4,003
| New | +$18K | ﹤0.01% | 3927 |
|
|
2016
Q1 | – | Sell |
-482
| Closed | -$5K | – | 4164 |
|
|
2015
Q4 | $5K | Sell |
482
-754
| -61% | -$7.82K | ﹤0.01% | 2939 |
|
|
2015
Q3 | $17K | Buy |
1,236
+262
| +27% | +$3.6K | ﹤0.01% | 1867 |
|
|
2015
Q2 | $14K | Buy |
974
+236
| +32% | +$3.39K | ﹤0.01% | 2399 |
|
|
2015
Q1 | $12K | Buy |
738
+408
| +124% | +$6.63K | ﹤0.01% | 2622 |
|
|
2014
Q4 | $5K | Buy |
+330
| New | +$5K | ﹤0.01% | 2685 |
|
|
2014
Q2 | – | Sell |
-40
| Closed | -$1K | – | 4058 |
|
|
2014
Q1 | $1K | Buy |
+40
| New | +$1K | ﹤0.01% | 4114 |
|